Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS: PVCT · Delayed Price · USD
0.195
0.00 (-0.10%)
Apr 19, 2024, 3:58 PM EDT - Market closed
PVCT Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.56 | 0.99 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.18 | Upgrade
|
| Revenue Growth (YoY) | -43.61% | - | - | - | - | - | - | - | - | - | Upgrade
|
| Cost of Revenue | 0.01 | 0.06 | 0.09 | 0.32 | 0.76 | 0 | 13.72 | 24.51 | 24.65 | 12,633 | Upgrade
|
| Gross Profit | 0.55 | 0.93 | -0.09 | -0.32 | -0.76 | 0 | -13.72 | -24.51 | -24.65 | -12,628.85 | Upgrade
|
| Selling, General & Admin | 1.73 | 2.02 | 2.05 | 2.14 | 2.3 | 3.31 | 5.52 | 15.97 | 13.27 | 11 | Upgrade
|
| Research & Development | 1.74 | 2.39 | 2.61 | 2.81 | 4 | 4.75 | 8.2 | 8.54 | 10.71 | 5.14 | Upgrade
|
| Other Operating Expenses | 0 | -1.02 | -0.03 | -0.03 | -0.13 | -0.03 | 0 | 0 | 0.67 | 0.67 | Upgrade
|
| Operating Expenses | 3.47 | 3.39 | 4.64 | 4.93 | 6.17 | 8.03 | 13.72 | 24.51 | 24.65 | 16.81 | Upgrade
|
| Operating Income | -2.93 | -3.43 | -4.67 | -4.96 | -6.3 | -8.01 | -13.72 | -24.51 | -24.65 | -12.63 | Upgrade
|
| Interest Income | 0 | 0.16 | 0 | 0 | 0.02 | 0.02 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Expense | -0.22 | 0.16 | 0.96 | 1.75 | 1.46 | 0.97 | -0.2 | -0.08 | -0.15 | -2.39 | Upgrade
|
| Other Expense / Income | 0.41 | 0.13 | -0.09 | -0.03 | -0.81 | 0.02 | 0.41 | 0.17 | 0.3 | 4.78 | Upgrade
|
| Pretax Income | -3.12 | -3.55 | -5.54 | -6.68 | -6.92 | -8.15 | -13.52 | -24.43 | -24.5 | -10.24 | Upgrade
|
| Income Tax | -0.02 | -0 | 0.96 | 1.75 | 1.46 | -0.83 | -0.41 | -0.17 | -0.3 | -4.78 | Upgrade
|
| Net Income | -3.1 | -3.55 | -6.5 | -8.43 | -8.38 | -8.15 | -13.52 | -24.43 | -24.5 | -10.24 | Upgrade
|
| Shares Outstanding (Basic) | 420 | 419 | 408 | 393 | 387 | 382 | 369 | 234 | 196 | 176 | Upgrade
|
| Shares Outstanding (Diluted) | 420 | 419 | 408 | 393 | 387 | 382 | 369 | 234 | 196 | 176 | Upgrade
|
| Shares Change | 0.01% | 2.76% | 3.81% | 1.72% | 1.11% | 3.55% | 57.89% | 19.52% | 11.28% | 33.20% | Upgrade
|
| EPS (Basic) | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.04 | -0.10 | -0.13 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.01 | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.04 | -0.10 | -0.13 | -0.06 | Upgrade
|
| Free Cash Flow | -2.57 | -3.04 | -1.01 | -4.09 | -6.19 | -5.2 | -10.38 | -21.94 | -17.42 | -13.92 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.00 | -0.01 | -0.02 | -0.01 | -0.03 | -0.09 | -0.09 | -0.08 | Upgrade
|
| Gross Margin | 98.40% | 93.55% | - | - | - | - | - | - | - | -302245.26% | Upgrade
|
| Operating Margin | -524.55% | -346.59% | - | - | - | - | - | - | - | -302.35% | Upgrade
|
| Profit Margin | -556.16% | -359.36% | - | - | - | - | - | - | - | -245.14% | Upgrade
|
| Free Cash Flow Margin | -461.17% | -307.52% | - | - | - | - | - | - | - | -333.10% | Upgrade
|
| EBITDA | -2.92 | -3.38 | -4.62 | -4.69 | -5.46 | -7.32 | -13.24 | -23.91 | -24.12 | -14.34 | Upgrade
|
| EBITDA Margin | -522.95% | -341.80% | - | - | - | - | - | - | - | -343.28% | Upgrade
|
| Depreciation & Amortization | 0.01 | 0.01 | 0.01 | 0.24 | 0.69 | 0.69 | 0.69 | 0.68 | 0.68 | 0.68 | Upgrade
|
| EBIT | -2.93 | -3.39 | -4.64 | -4.93 | -6.14 | -8.01 | -13.93 | -24.6 | -24.81 | -15.02 | Upgrade
|
| EBIT Margin | -524.55% | -342.90% | - | - | - | - | - | - | - | -359.55% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.